Sartorius Stedim Biotech (DIM) Stock Price, News & Analysis

+12.20 (+6.21%)
(As of 04/23/2024 ET)
Today's Range
50-Day Range
52-Week Range
106,382 shs
Average Volume
Market Capitalization
P/E Ratio
Dividend Yield
Price Target
DIM stock logo

About Sartorius Stedim Biotech Stock (EPA:DIM)

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.

DIM Stock Price History

DIM Stock News Headlines

At first glance, this chart looks like nonsense…
We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”
Sartorius Stedim Biotech S.A.
Sartorius Stedim Biotech (EPA:DIM) Stock Price Down 1.5%
Sartorius Stedim Biotech publishes unaudited -2-
$25,000 into $109,616 in two months?
Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…
Sartorius Stedim Biotech S.A. announces an -2-
Sartorius Stedim Biotech SA
Sartorius Stedim Biotech publishes preliminary, -3-
Sartorius Stedim Biotech S.A. (DIM.PA)
Sartorius Stedim Biotech S.A. ADR
Short-Sellers Sink One of Europe’s Hottest Stocks
US Futures Rise Slightly, European Stocks Mixed
See More Headlines
Receive DIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Medical Instruments & Supplies
Year Founded


Pretax Margin


Sales & Book Value

Annual Sales


Free Float
Not Optionable
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Dr. Rene Faber (Age 49)
    CEO & DIrector
    Comp: $540k
  • Mr. Rainer Lehmann (Age 49)
    CFO & Member of Executive Board
  • Ms. Petra Muller
    Head of Investor Relations
  • Ms. Petra Kirchhoff (Age 55)
    Head of Corporate Communications & IR
  • Olivier Guitard
    Head of Controlling BPS

DIM Stock Analysis - Frequently Asked Questions

How have DIM shares performed in 2024?

Sartorius Stedim Biotech's stock was trading at €239.50 at the beginning of 2024. Since then, DIM stock has decreased by 12.9% and is now trading at €208.70.
View the best growth stocks for 2024 here

What other stocks do shareholders of Sartorius Stedim Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sartorius Stedim Biotech investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP).

This page (EPA:DIM) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners